A probiotic bioengineered by UBC Okanagan researchers to thrive in the inflamed gut is set to enter human clinical trials in Australia this summer, capping a decade-long effort to turn a beneficial bacterium into a treatment ...
Jun 19, 2026
0
5
A new gene therapy has been used to successfully treat a deadly childhood liver disease in mice that model the disease, according to researchers at UCL and Great Ormond Street Hospital. Arthrogryposis, renal dysfunction and ...
Jun 19, 2026
0
22
Metabolic dysfunction-associated steatohepatitis (MASH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are progressive chronic liver diseases linked to abnormal bile acid metabolism. Although ...
Jun 18, 2026
0
4
Microplastics—minuscule pieces of plastic broken down from larger plastic waste—are a growing concern for human health, especially for the liver. A study from the University of Oklahoma, published in Science Advances, demonstrates ...
Jun 18, 2026
0
9
As new colorectal cancer screening guidance draws attention to the growing number of testing options, the American Gastroenterological Association urges patients and primary care providers to understand how those options ...
Jun 18, 2026
0
5
Scientists know that colorectal cancer cells require large amounts of iron and that as cancer becomes more aggressive, the cells have even higher amounts of iron. Normal cells with high levels of iron would undergo a type ...
Jun 17, 2026
0
21
The bacteria enterotoxigenic E. coli and Shigella together cause hundreds of millions of infections each year and are among the leading causes of diarrheal death, especially in children. Decades of vaccine development efforts ...
Jun 17, 2026
0
3
Immune checkpoint inhibitors are a form of cancer immunotherapy successfully used to treat a wide range of cancers. However, these treatments can cause side effects including immune-related colitis, or inflammation of the ...
Jun 17, 2026
0
5
Liver cancer is one of the fastest-rising causes of cancer-related deaths in the UK and the third-leading cause of cancer deaths worldwide.
Jun 17, 2026
0
2
The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most pressing chronic diseases.
Jun 17, 2026
0
6
